20Slash20 Inc., the creator of The Eye Drink, announced that CEO Dr. Roger Wu will deliver an investor presentation at the Moody Capital Solutions 2026 Disruptive Growth & Life Sciences Conference, scheduled for September 9–10, 2026, in New York City. The presentation is set for 9:35 a.m. ET on September 9 at The Westin New York Grand Central, with one-on-one meetings following.
The conference brings together growth companies, investors, and industry professionals across life sciences and other emerging sectors, providing a platform for 20Slash20 to highlight its unique position in the functional beverage market. The Eye Drink is the world’s first ready-to-drink beverage specifically formulated with science-backed ingredients to support eye health for individuals who spend extended hours daily on digital screens. As screen time continues to rise globally, the product addresses a growing concern: screen-induced eye problems such as digital eye strain, dryness, and fatigue.
This announcement underscores the increasing intersection of health and technology, as consumers seek proactive solutions to mitigate the effects of modern lifestyles. The Eye Drink offers a convenient and tasty alternative to traditional supplements, making it accessible for daily use. By participating in this conference, 20Slash20 aims to attract investor attention and secure partnerships that could accelerate its market penetration.
The significance of this presentation lies not only in the company’s fundraising potential but also in the validation of the functional beverage sector as a viable investment opportunity. With the global eye health market projected to grow, products like The Eye Drink could become essential for the digital workforce. The conference serves as a critical venue for 20Slash20 to communicate its value proposition to a targeted audience of investors and industry experts.
For more information about the conference and 20Slash20's participation, the full press release is available at https://ibn.fm/tm2lT. Investors and interested parties can also learn more about 20Slash20 and The Eye Drink through the company's official channels.
This event comes at a time when the beverage industry is witnessing a surge in functional products aimed at specific health benefits. From energy drinks to gut-health tonics, consumers are increasingly demanding more than just refreshment. The Eye Drink's focus on eye health taps into a niche yet widespread need, given that nearly everyone uses digital devices. By aligning with scientific research, 20Slash20 aims to build credibility and trust among health-conscious consumers.
As the conference approaches, 20Slash20's participation signals its readiness to scale operations and expand its footprint. The company's commitment to innovation and its unique product offering could position it favorably in the competitive beverage market. This presentation is a pivotal step for 20Slash20 to secure the resources needed to bring The Eye Drink to a broader audience and potentially revolutionize how we approach eye care in the digital age.
